Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
TRPC6 is a nonselective cation channel belonging to the TRP superfamily. It is activated by diacylglycerol and mechanical stretch, playing critical roles in regulating vascular tone, podocyte function in the kidney, and neuronal signaling. Its dysfunction is implicated in kidney diseases like FSGS, pulmonary hypertension, and cardiac hypertrophy, making it a potential therapeutic target.
Activation by diacylglycerol binding or mechanical stretch, leading to cation influx (primarily calcium)
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Transient Receptor Potential Cation Channel, Subfamily C, Member 6 (TRPC6).